MoneyWorks4Me

Hester Biosciences informs about board meeting

22 Jan 2025 Evaluate
Hester Biosciences has informed that, as per Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended from time to time), a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 30 January 2025, to consider the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31st December 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1850.80
Dr. Reddys Labs. 1210.80
Cipla 1374.50
Lupin 2095.55
Zydus Lifesciences 1161.35
View more..